I n the four months since he began serving as secretary of the Department of Health and Human Services, Robert F. Kennedy Jr. has made many public statements about vaccines that have cast doubt on ...

RFK Jr’s newly appointed vaccine panel votes to restrict thimerosal in flu shots, reviving decades-old controversy over a ...

As critics rally outside, a newly appointed committee signals a dramatic shift in U.S. immunization strategy, raising fears ...

When RFK Jr. announced he would cut funds from Gavi, the Vaccine Alliance, he cited “vaccine safety,” referring to a 2017 ...

While Thursday’s debate involved only a small fraction of flu vaccines, some public health experts contend the discussion unnecessarily raised doubt about vaccine safety.

After RFK Jr. overhauls CDC panel, measles and flu vaccines are up for debate The new ACIP agenda includes MMRV and thimerosal-containing flu vaccines. Beth Mole – Jun 18, 2025 4:42 pm | 168 ...

Health and Human Services Secretary Robert F. Kennedy Jr. pledged to appoint experts to a vaccine safety advisory panel seeking to apply “evidence-based decision-making with objectivity” in ...

RFK Jr. says U.S. will stop funding Gavi over 'vaccine safety' issues : Goats and Soda The secretary of health and human services said that funding will be curtailed until Gavi, the Vaccine ...

Two days after he fired all 17 members of a committee that advises the federal government on vaccine safety, Health Secretary Robert F. Kennedy, Jr. announced eight new members, including a ...

A day after abruptly firing the entire committee that advises the federal government on vaccine safety, Health and Human Services Secretary Robert F. Kennedy Jr. said he would reconstitute it with ...

Recently fired members of a committee that advises the federal government on immunization safety lashed out at Health and Human Services Secretary Robert F. Kennedy Jr., saying that their ...

When RFK Jr. announced he would cut funds from Gavi, the Vaccine Alliance, he cited "vaccine safety," referring to a 2017 study from Guinea-Bissau. We asked vaccine researchers to assess the study.